Real-World Evidence and
Health Economics Outcomes Research
Congress Materials
2026: Systemic Inflammation and Its Association with Major Adverse Cardiovascular Events in Patients with Acute Myocardial Infarction
NEXUS 2025: Economic Burden Associated with Systemic Inflammation in Patients with Established Atherosclerotic Cardiovascular Disease and Stage 3-4 Chronic Kidney Disease
NEXUS 2025: Healthcare Resource Utilization and Costs in Patients with Metabolic Dysfunction-Associated Steatohepatitis: A Comparison Between Patients with Probable MASH, Without MASH, and Diagnosed MASH
NEXUS 2025: Real-World Healthcare Resource Utilization and Costs Among 100% Fee-For-Service Medicare Beneficiaries With Metabolic Dysfunction-Associated Steatohepatitis
Search Novo Nordisk Medical
Novo Nordisk Medical is a resource for U.S. Healthcare Professionals to learn more about disease states investigated by Novo Nordisk and our related products. It provides evidence-based information on a variety of topics important to patient care. All information is for educational purposes only and is not intended to promote any products.
Find more information
Find product information
Survey Novo Nordisk’s portfolio of products and resources for the treatment of diabetes, obesity, liver health, and cardiovascular disease and treatments for rare bleeding, rare endocrine, and rare renal disorders.
Continuing education
Learn about accredited CE activities developed by third-party providers and supported by Novo Nordisk via independent medical education grants.
The purpose of this site is to provide relevant medical and scientific information about Novo Nordisk products and areas of therapeutic interest. Information about investigational products or investigational uses of approved products neither implies FDA approval for these products or uses, nor establishes the safety or efficacy of these products or uses. There is no guarantee that any investigational product or investigational use will receive FDA approval or become commercially available in the United States. Novo Nordisk does not recommend or suggest use of its products in any manner inconsistent with FDA-approved labeling.
This site is intended for United States healthcare professionals only. The information on this site—including all product information—pertains to residents of the United States only. Any products referenced on this site may have different labelling in different countries.
